China (Mainland)
- Product Details
Keywords
- Imatinib mesylate
- methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-y
- Imatinib Methanesulfonate
Quick Details
- ProName: Imatinib mesylate
- CasNo: 220127-57-1
- Molecular Formula: C29H31N7O.CH4O3S
- Appearance: Light yellow crystalline powder
- Application: Anti-cancer
- DeliveryTime: 10~15days
- PackAge: 20kg/Fiber drum
- Port: Shanghai, Wuhan
- ProductionCapacity: 200 Kilogram/Month
- Purity: 99%
- Storage: stored with sealed
- Transportation: By air
- LimitNum: 1 Kilogram
Superiority
ISO9001
|
Certification Name |
Certified By |
Certificate No. |
Product Name |
Available Date---Expired Date |
|
ISO 9001:2008 |
Moody Internaional Certification Ltd. |
121001006 |
Development and Production of API |
2010/04/01---2013-03/31 |
ISO14000
|
Certification Name |
Certified By |
Certificate No. |
Product Name |
Available Date---Expired Date |
|
ISO 14001:2004 |
Moody Internaional Certification Ltd. |
111001038 |
Development and Production of API |
2010/06/17---2013-06/16 |
OHSAS18000
|
Certification Name |
Certified By |
Certificate No. |
Product Name |
Available Date----Expired Date |
|
BS-OHSAS 18001:2007
|
Moody Internaional Certification Ltd. |
7648 |
Development and Production of API |
2010/06/16---2013-06/15 |
Details
【Company Profile】
Company Name: Hubei Haosun Pharmaceutical Co., Ltd.
Year Established: 2003
Main Products: Active pharmaceutical ingredients, completed product, cosmetics health food, etc.
【Specification】
Standard: In-house standard
Purity: 99%
Appearance: Light yellow crystalline powder
Manufacturing site & facility approved by FDA, SFDA, MHRA, COFEPRIS
【Application】
Imatinib is used to treatonic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) a number of other malignancies.
ISO9001
ISO14000
OHSAS18000
